Placebo (0.9% sodium chloride)

DRUG4 trials

Sponsors

PhaseBio Pharmaceuticals Inc., Shanghai Jiao Tong University School of Medicine, Bernd Jilma, YingHsuanTai

Conditions

Bariatric Surgery CandidateCongenital Heart DefectsEndotoxemiaGastric RefluxHealthy VolunteersHyperglycemia Drug InducedNausea and Vomiting, PostoperativeObesity

Phase 2

Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM

CompletedNCT01658501

PhaseBio Pharmaceuticals Inc.Type 2 Diabetes Mellitus

Start: 2012-07-31End: 2013-07-31Updated: 2015-12-07

Phase 4

Defibrotide in the Human Endotoxemia Model --- an Exploratory Trial Investigating the Effects and the Mechanisms of Defibrotide

CompletedNCT02876601

Bernd JilmaEndotoxemia, Healthy Volunteers

Start: 2017-04-18End: 2018-02-12Updated: 2019-12-19

Unknown Phase

Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of Fallot

CompletedNCT01941576

Shanghai Jiao Tong University School of MedicineCongenital Heart Defects, Tetralogy Of Fallot

Start: 2013-09-01End: 2019-07-20Updated: 2020-10-28

Multi-Strategy Intervention for Anesthesia Care of Obese Patients A Factorial Randomized Controlled Trial

WithdrawnNCT05016076

YingHsuanTaiBariatric Surgery Candidate, Gastric Reflux, Hyperglycemia Drug Induced +3

Start: 2022-05-31End: 2023-08-31Updated: 2022-05-24